Product Information
RIZATRIPTAN 5 MG ODT is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.5977 per EA under NDC 33342009373. Its NADAC has been published 457 times since Aug 17, 2016.
FDA first approved this application on Sep 19, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342009373
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA203146FDA Approved
9/19/2014
TE Code
AB
On Market Since
9/23/2014
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG ODT has been published 457 times since Aug 17, 2016, and over the history we have for it it has declined 48.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5977 per EA |
|---|---|
| All-time high | $1.3658 (Dec 16, 2020) |
| All-time low | $0.4078 (Jul 17, 2024) |
| Median price | $0.9869 |
| Average price | $0.9173 |
| Largest weekly change | +69.8% (Aug 21, 2024) |
| Weeks tracked | 457 |
| Tracking since | Aug 17, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-10.8%
5Y
-39.3%
All
-48.8%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG ODT, manufactured by Macleods Pharmaceuticals Limited, is $0.5977 per EA (NDC 33342009373), effective May 14, 2025.
How has the price of RIZATRIPTAN 5 MG ODT changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG ODT has declined 48.8%. It has been tracked across 457 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG ODT?
Since Aug 17, 2016, the NADAC for RIZATRIPTAN 5 MG ODT has ranged from a low of $0.4078 (Jul 17, 2024) to a high of $1.3658 (Dec 16, 2020), with a median of $0.9869 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG ODT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG ODT, is $0.5150 per EA — about 14% below RIZATRIPTAN 5 MG ODT.
Who manufactures RIZATRIPTAN 5 MG ODT?
RIZATRIPTAN 5 MG ODT (NDC 33342009373) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.